Biotechnology Companies By Eps

Earnings Per Share
Earnings Per ShareEfficiencyMarket RiskExp Return
1ALLR Allarity Therapeutics
2625.43
(0.13)
 4.70 
(0.61)
2FWBI First Wave BioPharma
1131.4
 0.08 
 11.47 
 0.87 
3SPRC Scisparc
919.88
(0.03)
 13.10 
(0.42)
4CALC CalciMedica Common Stock
82.57
 0.10 
 7.75 
 0.76 
5SLDB Solid Biosciences LLC
73.71
 0.19 
 11.80 
 2.22 
6REGN Regeneron Pharmaceuticals
34.77
 0.25 
 1.11 
 0.27 
7UTHR United Therapeutics
19.82
(0.05)
 1.63 
(0.09)
8VRTX Vertex Pharmaceuticals
13.88
 0.16 
 2.03 
 0.32 
9AMGN Amgen Inc
12.49
 0.02 
 1.39 
 0.03 
10APRE Aprea Therapeutics
12.31
 0.22 
 7.41 
 1.64 
11BNTX BioNTech SE
12.22
(0.08)
 2.18 
(0.17)
12BIIB Biogen Inc
7.96
(0.05)
 1.70 
(0.08)
13ROIV Roivant Sciences
5.27
 0.11 
 2.32 
 0.26 
14GILD Gilead Sciences
4.5
(0.06)
 1.83 
(0.11)
15ARCT Arcturus Therapeutics Holdings
3.76
 0.21 
 4.34 
 0.89 
16ZYME Zymeworks Common Stock
3.23
 0.16 
 3.00 
 0.48 
17ALKS Alkermes Plc
3.06
 0.08 
 2.89 
 0.24 
18MEIP MEI Pharma
2.98
(0.24)
 2.84 
(0.67)
19ABBV AbbVie Inc
2.72
 0.38 
 0.89 
 0.34 
20INCY Incyte
2.65
 0.06 
 2.03 
 0.12 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure. Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.